Markus Tiemann

7.5k total citations
134 papers, 4.3k citations indexed

About

Markus Tiemann is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Markus Tiemann has authored 134 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 53 papers in Oncology and 29 papers in Immunology. Recurrent topics in Markus Tiemann's work include Lymphoma Diagnosis and Treatment (60 papers), Viral-associated cancers and disorders (26 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Markus Tiemann is often cited by papers focused on Lymphoma Diagnosis and Treatment (60 papers), Viral-associated cancers and disorders (26 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Markus Tiemann collaborates with scholars based in Germany, United States and Russia. Markus Tiemann's co-authors include Reza Parwaresch, Alfred Reiter, P Korbjuhn, Parwaresch Mr, Igor Buchwalow, Michael Hummel, Wolfgang Ludwig, Martin Schrappe, F Dallenbach and Werner Boecker and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Markus Tiemann

126 papers receiving 4.2k citations

Peers

Countries citing papers authored by Markus Tiemann

Since Specialization

Citations

This map shows the geographic impact of Markus Tiemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Tiemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Tiemann more than expected).

Fields of papers citing papers by Markus Tiemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Tiemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Tiemann. The network helps show where Markus Tiemann may publish in the future.

Co-authorship network of co-authors of Markus Tiemann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Tiemann. A scholar is included among the top collaborators of Markus Tiemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Tiemann. Markus Tiemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis 2024 ·Journal of Histochemistry & Cytochemistry ·Dmitri Atiakshin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sergey Baiko, (unknown), (unknown), Daniel Elieh Ali Komi, Igor Buchwalow, Markus Tiemann	3
2	Mitochondrial DNA Mutations in Colorectal Cancer Stem Cells:Implications for Tumor Dynamics and Therapeutic Strategies 2024 ·Current Medicinal Chemistry ·(unknown), Л.М. Михалева, (unknown), (unknown), (unknown), (unknown), (unknown), Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann, Alexander N. Orekhov	0
3	The Contribution of Mast Cells to the Regulation of Elastic Fiber Tensometry in the Skin Dermis of Children with Marfan Syndrome 2024 ·International Journal of Molecular Sciences ·Dmitri Atiakshin, (unknown), (unknown), (unknown), (unknown), S. V. Morozov, (unknown), Л.М. Михалева, Grigory Demyashkin, Daniel Elieh Ali Komi, Igor Buchwalow, Markus Tiemann	2
4	Signaling Pathways in the Pathogenesis of Barrett’s Esophagus and Esophageal Adenocarcinoma 2023 ·International Journal of Molecular Sciences ·(unknown), Л.М. Михалева, (unknown), (unknown), (unknown), Dmitri Atiakshin, Igor Buchwalow, Markus Tiemann	6
5	Money laundering, media and European banks 2023 ·Journal of Money Laundering Control ·Markus Tiemann	0
6	Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study 2021 ·Journal of Medical Internet Research ·Max Schmitt, Roman C. Maron, Achim Hekler, Albrecht Stenzinger, Axel Hauschild, Michael Weichenthal, Markus Tiemann, Dieter Krahl, Heinz Kutzner, Jochen Utikal, Sebastian Haferkamp, Jakob Nikolas Kather, Frederick Klauschen, Eva Krieghoff‐Henning, Stefan Fröhling, Christof von Kalle, Titus J. Brinker	40
7	BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy 2021 ·European Journal of Cancer ·Marcel Wiesweg, (unknown), (unknown), Martin Metzenmacher, Wilfried Eberhardt, (unknown), (unknown), Henning Reis, Thomas Herold, Kaid Darwiche, Clemens Aigner, Martin Stuschke, Hans‐Ulrich Schildhaus, Kurt Werner Schmid, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Frank Griesinger, Martin Schüler	12
8	Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas 2016 ·Modern Pathology ·Andreas H. Scheel, Manfred Dietel, Lukas C. Heukamp, Korinna Jöhrens, Thomas Kirchner, Simone Reu, Josef Rüschoff, Hans‐Ulrich Schildhaus, Peter Schirmacher, Markus Tiemann, Arne Warth, Wilko Weichert, Rieke Fischer, Jürgen Wolf, Reinhard Buettner	268
9	Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases 2011 ·Journal of Clinical Oncology ·(unknown), Berthold Streubel, Elisabeth Kretschmer‐Chott, Andreas Püspök, Ulrich Jäger, Christine Mannhalter, Markus Tiemann, German Ott, Wolfgang Fischbach, Peter Herzog, Gerhard Seitz, Manfred Stolte, Markus Raderer, Andreas Chott	152
10	Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia 2008 ·The Journal of Immunology ·Birte Friedrichs, Sandra Siegel, Marita Kloess, Adel L. Barsoum, Joseph H. Coggin, James W. Rohrer, (unknown), Markus Tiemann, Klaus Heidorn, Christoph Schulte, Dieter Kabelitz, Jörg Steinmann, Norbert Schmitz, Matthias Zeis	15
11	Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease 2005 ·European Journal Of Haematology ·Christiane Pott, Carsten Schrader, Monika Brüggemann, Matthias Ritgen, Lana Harder, Thorsten Raff, Markus Tiemann, Peter Dreger, Michael Kneba	17
12	Mucosa-associated lymphoid tissue lymphoma in the conjunctiva of a child 2004 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Markus Tiemann, (unknown), (unknown), (unknown), Alexander Claviez	18
13	Lymphome der Kopfspeicheldr�sen 2004 ·Der Pathologe ·Markus Tiemann, Afshin Teymoortash, Hermann Herbst	7
14	Characterization of lymphoid infiltrates in chronic obstructive sialadenitis associated with sialolithiasis 2004 ·Journal of Oral Pathology and Medicine ·Afshin Teymoortash, Markus Tiemann, Carsten Schrader, Jochen A. Werner	16
15	Cytogenetic and molecular characterization of a patient with simultaneous B‐cell chronic lymphocytic leukemia and peripheral T‐cell lymphoma 2001 ·American Journal of Hematology ·José I. Martı́n-Subero, Reiner Siebert, Lana Harder, Stefan Gesk, Peter Schwindt, Andreas Bräuninger, Klaus Willenbrock, Doris Steinemann, Markus Tiemann, Marı́a José Calasanz, W. Grote, Wolfgang Ludwig, Martin‐Leo Hansmann, Brigitte Schlegelberger	13
16	Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression 2001 ·Journal of Dermatological Science ·Sujala Kapur, Martin A. O. H. Menke, Markus Tiemann, Christoph Schubert, Reza Parwaresch	8
17	Klonale B-Zell Reaktion bei M. Sjögren und Autoimmunthyreoiditis Hashimoto 1996 ·Der Pathologe ·Markus Tiemann, (unknown), (unknown)	6
18	Therapiestudie NHL-BFM 90 zur Behandlung maligner Non-Hodgkin-Lymphome bei Kindern und Jugendlichen - Teil 1: Klassifikation und Einteilung in strategische Therapiegruppen 1994 ·Klinische Pädiatrie ·Alfred Reiter, Markus Tiemann, W.-D. Ludwig, H.-H. Wacker, Elif Yakisan, Martin Schrappe, Dietrich Henzler, Karl W. Sykora, Alan E. Brandt, E. Odenwald, H. Riehm, Reza Parwaresch	17
19	Peripheral T‐cell non‐Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T‐zone lymphoma 1994 ·British Journal of Haematology ·W. Siegert, Christoph Nerl, M. Engelhard, Günter Brittinger, Markus Tiemann, Reza Parwaresch, R. Heinz, D. Huhn	13
20	Mitoxantrone, Etoposide and Prednisolone (NOVEP) in Previously Untreated Elderly Patients with Non-Hodgkin’s Lymphoma (NHL) and as Salvage Therapy for Refractory NHL 1993 ·Oncology Research and Treatment ·Torsten Haferlach, W. Gaßmann, L. Uharek, Markus Tiemann, H. Löffler	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact